NeoGenomics Secures Medicare Coverage for RaDaR ST Assay
Discover how Medicare coverage for NeoGenomics' RaDaR ST assay enhances cancer treatment monitoring and patient management options.
Seattle Man Sentenced for $1M Medicare Fraud Scheme Involving Lab Testing
An Everett-based lab operator was sentenced to prison for a $1.17M Medicare fraud scheme involving fraudulent billing for unperformed COVID-19 and respiratory tests. The case underscores ongoing regulatory challenges.
FDA Approves First Blood Test to Aid Alzheimer’s Diagnosis
The FDA has approved Lumipulse, the first blood test for Alzheimer's diagnosis in symptomatic older adults, enabling less invasive detection of amyloid plaques and supporting earlier, accurate diagnosis and treatment options.